Nevro News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.11.18	ONCS Hits New Low, AAC Trims Revenue Outlook, NVRO Down 45% YTD (RTTNews)
17.07.18	EOLS Slumps On Stock Offering, BLCM CFO To Exit, NVRO Trims Revenue Outlook (RTTNews)
23.05.18	The Future of Infrastructure Design: Data-Centric Architecture (PR Newswire)
14.05.18	Nevro Recognized as a "Best Place to Work" in the Bay Area (PR Newswire)
07.05.18	Nevro Reports First Quarter 2018 Financial Results (PR Newswire)
02.05.18	Nevro to Present at the Bank of America Merrill Lynch 2018 Health Care Conference (PR Newswire)
23.04.18	Nevro to Report Operating Results for the First Quarter 2018 (PR Newswire)
22.03.18	Full-Body MRI Conditional Labeling Now Available in United States for Nevro Senza® Spinal Cord Stimulation System (PR Newswire)
22.02.18	Nevro Reports Fourth Quarter and Full Year 2017 Financial Results and Provides 2018 Outlook (PR Newswire)
08.02.18	Nevro to Report Operating Results for the Fourth Quarter and Full Year 2017 (PR Newswire)
01.02.18	Neuer, kleinerer Impulsgenerator für die HF10-Therapie: Erste Implantationen an vier Kompetenzzentren (PR Newswire)
12.01.18	Nevro to Highlight Body of Clinical Evidence Supporting Expanded Use and Potential New Indications of Company's Senza Spinal Cord Stimulation Systems Delivering HF10™ Therapy at NANS Annual Meeting (PR Newswire)
09.01.18	Parkinson's Drug Hits Shelves, Major Event Awaits ABIO In Mar, FDA Nod For NVRO (RTTNews)
08.01.18	Nevro Receives FDA Approval for Senza II™ Spinal Cord Stimulation System Delivering HF10™ Therapy (PR Newswire)
08.01.18	Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2017 Revenue (PR Newswire)
01.12.17	Nevro erhält CE-Kennzeichnung für Senza II™ Rückenmark-Stimulationssystem zur Bereitstellung der HF10™-Therapie (PR Newswire)
01.12.17	Nevro obtient le marquage CE pour Senza II™, son système de stimulation de la moelle épinière administrant la thérapie HF10™ (PR Newswire)
30.11.17	Nevro Receives CE Mark for Senza II™ Spinal Cord Stimulation System Delivering HF10™ Therapy (PR Newswire)
15.11.17	Nevro Receives CE Mark for Full-Body MRI Conditional Labeling with the Senza® Spinal Cord Stimulation System (PR Newswire)
06.11.17	Nevro Reports Third Quarter 2017 Financial Results (PR Newswire)
23.10.17	Nevro to Report Operating Results for the Third Quarter 2017 (PR Newswire)
24.08.17	Nevro to Present at Upcoming Investor Conferences (PR Newswire)
18.08.17	Today's Research Report Coverage on Medical Equipment Stocks -- Avinger, ViewRay, EnteroMedics, and Nevro (PR Newswire)
07.08.17	Nevro Reports Second Quarter 2017 Financial Results (PR Newswire)
26.07.17	Nevro to Present at the Canaccord Genuity Growth Conference (PR Newswire)
24.07.17	Nevro to Report Operating Results for the Second Quarter 2017 (PR Newswire)
13.07.17	Medical Equipment Stock Performance Review -- Nevro, EnteroMedics, Avinger, and ViewRay (PR Newswire)
06.07.17	Gainers & Losers Of July 5: CALA, NVRO, BPMC, KMPH, FLDM... (RTTNews)
05.07.17	Nevro Announces Preliminary Unaudited Second Quarter 2017 Revenue and Business Update (PR Newswire)
16.06.17	Neurosurgery Selects the SENZA-RCT 24-Month Outcomes Publication as the Top Pain Paper of the Year (PR Newswire)
10.05.17	How These Medical Equipment Stocks are Faring? -- Steris, NuVasive, Smith & Nephew, and Nevro (PR Newswire)
08.05.17	Nevro Reports First Quarter 2017 Financial Results (PR Newswire)
02.05.17	Nevro to Present at the Bank of America Merrill Lynch 2017 Health Care Conference (PR Newswire)
24.04.17	Nevro to Report Operating Results for the First Quarter 2017 (PR Newswire)
22.03.17	Recent Developments in the Electrophysiology Markets (PR Newswire)
23.02.17	Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook (PR Newswire)
17.02.17	How These Medical Equipment Stocks are Faring? -- Smith & Nephew, ABIOMED, Nevro, and Steris (PR Newswire)
09.02.17	Nevro to Report Operating Results for the Fourth Quarter and Full Year 2016 (PR Newswire)
28.12.16	Research Reports Initiation on Medical Equipment Stocks -- Lantheus, Nevro, Steris, and Spectranetics (PR Newswire)
09.12.16	Nevro Announces Filing of Lawsuit by Boston Scientific (PR Newswire)
29.11.16	FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX (RTTNews)
29.11.16	Nevro Files Patent Infringement Lawsuit Against Units Of Boston Scientific (RTTNews)
29.11.16	Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S. (PR Newswire)
21.11.16	Technical Reports on Medical Equipment Equities -- Lantheus, Nevro, Steris, and Spectranetics (PR Newswire)
02.09.15	FLXN On Fast Track, WMGI Gets FDA Nod, RDHL Gearing Up, NVRO Awaits D-Day (RTTNews)
03.06.15	Nevro Prices Upsized Public Offering Of 4.71 Mln Shares At $51 Per Share (RTTNews)
11.05.15	NVRO Gets FDA Nod, ZFGN's Obesity Drug Proves Its Worth, HRTX Awaits MAGIC (RTTNews)
09.05.15	Nevro Gets FDA Approval For Senza Spinal Cord Stimulation System - Quick Facts (RTTNews)
02.12.14	Nevro Loss Widens (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Nevro Corp

Aktien Top/Flop

Meistgelesene Nachrichten